Elsevier

Academic Radiology

Volume 17, Issue 9, September 2010, Pages 1083-1089
Academic Radiology

Radiology Alliance for Health Services Research
Validation of a New Reference Standard for the Diagnosis of Vasospasm

https://doi.org/10.1016/j.acra.2010.04.025Get rights and content

Rationale and Objectives

The purpose of our study is to perform an internal validation of a new reference standard for vasospasm diagnosis in aneurysmal subarachnoid hemorrhage (A-SAH) patients.

Materials and Methods

A retrospective study was performed on A-SAH patients between January 2002 and May 2009. All patients were applied to this new reference standard using a multistage hierarchical approach incorporating clinical and imaging criteria. An internal validation method was performed in two phases to compare the new reference standard with digital subtraction angiography (DSA) and to assess accuracy. In Phase I, the diagnostic outcomes from DSA at the primary level were compared with the secondary/tertiary levels in the reference standard. In Phase II, the new reference standard was compared with chart diagnosis. Accuracy test characteristics, agreement rates, kappa values, and bias indices were calculated.

Results

In Phase I (n = 85), there was 87% agreement rate, 0.674 kappa, and 0.12 bias index. However, there was 100% agreement in patients diagnosed with vasospasm by DSA. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were 100%, 61%, 83%, and 100% respectively. In Phase II (n = 137), there was 91% agreement rate, 0.824 kappa, and 0.04 bias index. Sensitivity, specificity, PPV, and NPV were 88%, 95%, 96%, and 87%, respectively.

Conclusion

Performing validation methods for a new reference standard is an evolving and ongoing process because limitations and bias in the reference standard are identified. Based on the results of this internal validation, a modification in the new reference standard is made at the primary level, resulting in improvement in its accuracy and classification of A-SAH patients.

Section snippets

Study Population

We performed a retrospective study on consecutive patients admitted to our institution, with the diagnosis of A-SAH between January 2002 and May 2009. Inclusion criterion for the study was an admission diagnosis of A-SAH as determined by chart review. Institutional review board approval was obtained.

Study Design

All A-SAH patients were applied to this new multistage hierarchical reference standard in a stepwise manner. An advantage of using this reference standard is that no patients were excluded and all

Patients

A total of 137 patients were identified for inclusion in this study. Importantly, no patients were excluded from the study. There were 85 patients who had DSA performed during their hospital course and were included in Phase I of the study. However, all 137 patients were included in Phase II. Clinical and demographic data are presented in Table 1.

In Phase I (n = 85), using DSA at the primary level as the gold standard, vasospasm was diagnosed in 57 (67%) patients and no vasospasm in 28 (33%)

Discussion

Often times, a perfect gold standard does not exist in clinical or research practice. The accuracy of a new diagnostic test determined by using an imperfect gold standard introduces biases and inconsistencies in the results. In clinical practice, gold standards are rarer than one might think (11). For example, colposcopy-guided biopsy of the cervix has been considered the gold standard for disease detection of cervical neoplasia for decades; however, the sensitivity is only 60%, leading to

References (13)

There are more references available in the full text version of this article.

Cited by (8)

View all citing articles on Scopus

This publication was made possible by Grant Number 5K23NS058387-02 from the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NINDS or NIH.

View full text